© Copyright 2025 American Medical Association. All rights reserved.
Transcatheter renal sympathetic denervation is a minimally invasive procedure aimed at treating conditions such as hypertension, heart failure, renal dysfunction, and issues related to glucose control and sleep apnea, particularly when traditional lifestyle modifications and pharmacological treatments have proven ineffective. The underlying principle of this procedure is based on the understanding that heightened activity of the sympathetic nervous system, originating from the renal plexus, significantly contributes to the development of hypertension. By disrupting the nerve impulses that are transmitted from the renal plexus, this procedure effectively reduces sympathetic nervous system activity, thereby leading to a decrease in blood pressure levels. The technique employs a transcatheter endovascular approach, utilizing low-level radiofrequency energy that is precisely delivered through the renal artery wall to target the sympathetic nerves associated with the kidney. The procedure begins with the preparation of the skin over the access artery, typically one of the femoral arteries, followed by arterial puncture and the placement of a sheath. Heparin is administered to prevent clotting during the procedure. A guide wire is then navigated from the access artery into the aorta, positioning it appropriately for subsequent imaging and interventions. The use of fluoroscopy and contrast injections allows for detailed visualization of the renal vasculature, facilitating the accurate delivery of radiofrequency energy to interrupt nerve impulses. This innovative approach represents a significant advancement in the management of resistant hypertension and related conditions.
© Copyright 2025 Coding Ahead. All rights reserved.
The transcatheter renal sympathetic denervation procedure is indicated for the following conditions:
The transcatheter renal sympathetic denervation procedure involves several critical steps to ensure successful intervention:
Following the completion of the transcatheter renal sympathetic denervation procedure, patients are typically monitored for any immediate complications related to the vascular access site. It is essential to apply pressure to the access site to minimize the risk of bleeding. Patients may experience some discomfort or bruising at the puncture site, which is generally self-limiting. The healthcare team will provide instructions regarding activity restrictions and follow-up appointments to assess the effectiveness of the procedure and monitor blood pressure levels. Additional considerations may include managing any underlying conditions and adjusting medications as necessary based on the patient's response to the intervention.
Short Descr | TRNSCTH RENAL SYMP DENRV UNL | Medium Descr | TRANSCATHETER RENAL SYMPATH DENERVATION UNILAT | Long Descr | Transcatheter renal sympathetic denervation, percutaneous approach including arterial puncture, selective catheter placement(s) renal artery(ies), fluoroscopy, contrast injection(s), intraprocedural roadmapping and radiological supervision and interpretation, including pressure gradient measurements, flush aortogram and diagnostic renal angiography when performed; unilateral | Status Code | Carriers Price the Code | Global Days | YYY - Carrier Determines Whether Global Concept Applies | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Hospital Part B services paid through a comprehensive APC | ASC Payment Indicator | Non office-based surgical procedure added in CY 2008 or later; payment based on OPPS relative payment weight. | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | P6C - Minor procedures - other (Medicare fee schedule) | MUE | 1 |
This is a primary code that can be used with these additional add-on codes.
37252 | Addon Code MPFS Status: Active Code APC N ASC N1 Intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; initial noncoronary vessel (List separately in addition to code for primary procedure) | 37253 | Addon Code MPFS Status: Active Code APC N ASC N1 Intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; each additional noncoronary vessel (List separately in addition to code for primary procedure) |
Date
|
Action
|
Notes
|
---|---|---|
2014-01-01 | Added | Added |
Get instant expert-level medical coding assistance.